Powder: -20°C for 3 years | In solvent: -80°C for 1 year
NBD-556 is a small molecule mimetic of CD4. NBD-556 recognizes the HIV-1 envelope protein gp120 and induces restructuring of gp120 analogous to CD4 binding.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | In stock | $ 34.00 | |
5 mg | In stock | $ 55.00 | |
10 mg | In stock | $ 97.00 | |
25 mg | In stock | $ 162.00 | |
50 mg | In stock | $ 238.00 | |
100 mg | In stock | $ 358.00 | |
200 mg | In stock | $ 528.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 61.00 |
Description | NBD-556 is a small molecule mimetic of CD4. NBD-556 recognizes the HIV-1 envelope protein gp120 and induces restructuring of gp120 analogous to CD4 binding. |
In vitro | HIV NBD-556 N-phenyl-N′-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamide analogs as a novel class of human immunodeficiency virus type 1 (HIV-1) entry inhibitors that block the gp120–CD4 interaction. The small molecule NBD-556 mimics CD4 by binding the gp120 exterior envelope glycoprotein, moderately inhibiting virus entry into CD4-expressing target cells, and enhancing CCR5 binding and virus entry into CCR5-expressing cells lacking CD4. |
Molecular Weight | 337.84 |
Formula | C17H24ClN3O2 |
CAS No. | 333353-44-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: < 0.1 mg/mL (insoluble)
DMSO: 33.33 mg/mL (98.66 mM), Sonification is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
NBD-556 333353-44-9 Microbiology/Virology Proteases/Proteasome HIV Protease inhibit HIV-1 fusion virus-cell Human immunodeficiency virus HIV NBD 556 Inhibitor NBD556 gp120 CD4 mimetic inhibitor